Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 358

Results For "UST"

3932 News Found

AstraZeneca to set up API facility in Ireland at an investment of US $ 360 million
Supply Chain | September 21, 2021

AstraZeneca to set up API facility in Ireland at an investment of US $ 360 million

The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes


Zydus agrees to sell Mifegest and Cytolog to Integrace
News | September 21, 2021

Zydus agrees to sell Mifegest and Cytolog to Integrace

The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.


U.S. FDA approves Samsung Bioepis and Biogen’s BYOOVIZ biosimilar
Drug Approval | September 21, 2021

U.S. FDA approves Samsung Bioepis and Biogen’s BYOOVIZ biosimilar

It becomes the first ophthalmology biosimilar to gain FDA approval in the United States


Technology to distinguish between bacterial and viral infections cleared
Medical Device | September 21, 2021

Technology to distinguish between bacterial and viral infections cleared

MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes


RxDx Healthcare receives NABL accreditation
Diagnostic Center | September 20, 2021

RxDx Healthcare receives NABL accreditation

RxDx is a chain of primary care driven multispecialty healthcare clinics with two main branches situated in Whitefield and Malleswaram in Bengaluru


Imfinzi plus chemotherapy tripled patient survival at 3 years
Biotech | September 20, 2021

Imfinzi plus chemotherapy tripled patient survival at 3 years

The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting


Novartis’ Kisqali data indicates longest median survival in advanced breast cancer
Drug Approval | September 20, 2021

Novartis’ Kisqali data indicates longest median survival in advanced breast cancer

With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting


Pharmexcil exhibition and conference on Sept 21-22
Events | September 18, 2021

Pharmexcil exhibition and conference on Sept 21-22

The event will include an exhibition and sector-wise sessions for two days with participation by officials from the Ministry of Commerce, export promotion councils and members of the industry


Apollo Hospital Chennai completes India’s first robotic bariatric surgery
Hospitals | September 18, 2021

Apollo Hospital Chennai completes India’s first robotic bariatric surgery

This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports


Samhita and Cipla collaborate to study the role of pharmacists in healthcare
Public Health | September 18, 2021

Samhita and Cipla collaborate to study the role of pharmacists in healthcare

Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients